Metraipolis › archive › dc_f615d9879118

Methotrexate in relatively contraindicated ectopic pregnancies: who benefits from treatment? — Europe PMC PMID:42435070

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42435070
DOI
10.1007/s00404-[numero omesso]-4
License (as archived)
solo-consultazione
Archived
2026-10-18T08:25:16.746Z
SHA-256 of the archived text
f75ed8fed0c33cdbc0df643d99dddf34316780f9ee2dee9ead38549358a62e0a
Stable URL of this page
https://metraipolis.com/documento/dc_f615d9879118

How to cite

Methotrexate in relatively contraindicated ectopic pregnancies: who benefits from treatment? — Europe PMC PMID:42435070 — Europe PMC (en), https://europepmc.org/article/MED/42435070 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f615d9879118 (Metraipolis archive dc_f615d9879118, sha256 f75ed8fed0c33cdbc0df643d99dddf34316780f9ee2dee9ead38549358a62e0a)
BibTeX
@misc{dcf615d9879118,
  title = {Methotrexate in relatively contraindicated ectopic pregnancies: who benefits from treatment? — Europe PMC PMID:42435070},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42435070},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f615d9879118; sha256 f75ed8fed0c33cdbc0df643d99dddf34316780f9ee2dee9ead38549358a62e0a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42435070. Agents can read the archived copy with the MCP tool read_document.